Matches in SemOpenAlex for { <https://semopenalex.org/work/W4238454685> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W4238454685 abstract "Abstract BackgroundVaccination is a promising anticancer strategy, but the limited delivery routes and short retention of antigens and immunomodulatory agents are problems that need to be solved in vaccine design. Because silicon nanoparticles have a tunable pore size and high loading capacity, they have been used in a variety of drug delivery systems, but their roles in tumor vaccine and tumor immunotherapy need to be examined.MethodsCD40 mAb was attached to mesoporous silica nanoparticles (MSNs) through covalent conjunction, and MSN-CD40/OVA/CpG nanoparticles were examined by Fourier transform-infrared spectroscopy, transmission electron microscopy and nanoparticle analyzer. In vitro functions of nanoparticles were detected by cytotoxicity, cellular uptake, DC maturation, cross-presentation and T cell priming. In vivo functions were monitored by tumor elimination, DC maturation, cross-presentation and T cell activity.ResultsWe encapsulated anti-CD40 monoclonal antibodies, ovalbumin (OVA) antigen, and a toll-like receptor-9 agonist (CpG) in mesoporous silica nanoparticles (MSNs). The resulting MSN-CD40/OVA/CpG nanoparticles were efficiently phagocytized by splenocytes and bone marrow-derived dendritic cells (BMDC). The MSN-CD40/OVA/CpG nanoparticles induced the BMDC to express the costimulatory molecules CD80 and CD86, and release tumor necrosis factor-α. We found that MSN-CD40/OVA/CpG nanoparticles correctly enhanced antigen cross-priming, and stimulated T cell proliferation and interferon γ (IFNγ) production in vitro. In vivo, the MSN-CD40/OVA/CpG nanoparticles strongly increased intracellular IFNγ secretion and its release from OVA 257–264 peptide-specific splenocytes into the cell supernatant, induced dendritic cell expression of major histocompatibility complex-II, and stimulated lymphocyte CD80 and CD86 expression. The MSN-CD40/OVA/CpG nanoparticles also inhibited tumor growth, enhanced tumor infiltration of CD8 + and CD4 + T cells, and stimulated IFNγ secretion from splenocytes. In conclusion, we believe these MSN-CD40/OVA/CpG nanoparticles are a promising strategy for improving antigen cross-presentation, cytotoxic T lymphocyte immune activity, and anti-tumor immunotherapy." @default.
- W4238454685 created "2022-05-12" @default.
- W4238454685 creator A5014787907 @default.
- W4238454685 creator A5023874610 @default.
- W4238454685 creator A5026978497 @default.
- W4238454685 creator A5028946550 @default.
- W4238454685 creator A5058025282 @default.
- W4238454685 creator A5063046811 @default.
- W4238454685 creator A5066707494 @default.
- W4238454685 creator A5080931085 @default.
- W4238454685 creator A5082013054 @default.
- W4238454685 date "2020-10-09" @default.
- W4238454685 modified "2023-10-14" @default.
- W4238454685 title "Silica-Based Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy" @default.
- W4238454685 doi "https://doi.org/10.21203/rs.3.rs-87251/v1" @default.
- W4238454685 hasPublicationYear "2020" @default.
- W4238454685 type Work @default.
- W4238454685 citedByCount "0" @default.
- W4238454685 crossrefType "posted-content" @default.
- W4238454685 hasAuthorship W4238454685A5014787907 @default.
- W4238454685 hasAuthorship W4238454685A5023874610 @default.
- W4238454685 hasAuthorship W4238454685A5026978497 @default.
- W4238454685 hasAuthorship W4238454685A5028946550 @default.
- W4238454685 hasAuthorship W4238454685A5058025282 @default.
- W4238454685 hasAuthorship W4238454685A5063046811 @default.
- W4238454685 hasAuthorship W4238454685A5066707494 @default.
- W4238454685 hasAuthorship W4238454685A5080931085 @default.
- W4238454685 hasAuthorship W4238454685A5082013054 @default.
- W4238454685 hasBestOaLocation W42384546851 @default.
- W4238454685 hasConcept C147483822 @default.
- W4238454685 hasConcept C154317977 @default.
- W4238454685 hasConcept C185592680 @default.
- W4238454685 hasConcept C192562407 @default.
- W4238454685 hasConcept C202751555 @default.
- W4238454685 hasConcept C203014093 @default.
- W4238454685 hasConcept C2776090121 @default.
- W4238454685 hasConcept C2777701055 @default.
- W4238454685 hasConcept C2778170410 @default.
- W4238454685 hasConcept C2778297628 @default.
- W4238454685 hasConcept C2780674031 @default.
- W4238454685 hasConcept C2781101188 @default.
- W4238454685 hasConcept C39347974 @default.
- W4238454685 hasConcept C55493867 @default.
- W4238454685 hasConcept C67662055 @default.
- W4238454685 hasConcept C86803240 @default.
- W4238454685 hasConcept C8891405 @default.
- W4238454685 hasConcept C95444343 @default.
- W4238454685 hasConceptScore W4238454685C147483822 @default.
- W4238454685 hasConceptScore W4238454685C154317977 @default.
- W4238454685 hasConceptScore W4238454685C185592680 @default.
- W4238454685 hasConceptScore W4238454685C192562407 @default.
- W4238454685 hasConceptScore W4238454685C202751555 @default.
- W4238454685 hasConceptScore W4238454685C203014093 @default.
- W4238454685 hasConceptScore W4238454685C2776090121 @default.
- W4238454685 hasConceptScore W4238454685C2777701055 @default.
- W4238454685 hasConceptScore W4238454685C2778170410 @default.
- W4238454685 hasConceptScore W4238454685C2778297628 @default.
- W4238454685 hasConceptScore W4238454685C2780674031 @default.
- W4238454685 hasConceptScore W4238454685C2781101188 @default.
- W4238454685 hasConceptScore W4238454685C39347974 @default.
- W4238454685 hasConceptScore W4238454685C55493867 @default.
- W4238454685 hasConceptScore W4238454685C67662055 @default.
- W4238454685 hasConceptScore W4238454685C86803240 @default.
- W4238454685 hasConceptScore W4238454685C8891405 @default.
- W4238454685 hasConceptScore W4238454685C95444343 @default.
- W4238454685 hasLocation W42384546851 @default.
- W4238454685 hasOpenAccess W4238454685 @default.
- W4238454685 hasPrimaryLocation W42384546851 @default.
- W4238454685 hasRelatedWork W10770682 @default.
- W4238454685 hasRelatedWork W11882389 @default.
- W4238454685 hasRelatedWork W12333971 @default.
- W4238454685 hasRelatedWork W1283782 @default.
- W4238454685 hasRelatedWork W13366478 @default.
- W4238454685 hasRelatedWork W22435913 @default.
- W4238454685 hasRelatedWork W23476594 @default.
- W4238454685 hasRelatedWork W23912248 @default.
- W4238454685 hasRelatedWork W7493770 @default.
- W4238454685 hasRelatedWork W8387223 @default.
- W4238454685 isParatext "false" @default.
- W4238454685 isRetracted "false" @default.
- W4238454685 workType "article" @default.